A cannabis-based formulation developed by Australia's CannPal (ASX:CP1) has substantially reduced atopic dermatitis severity in dogs participating in clinical trial.Atopic dermatitis is triggered by...
A study of adult autism patients registered with UK Medical Cannabis Registry has indicated patients are generally experiencing an improvement in quality of life.The...
Initial conclusions of the combined first and second cohorts of a US cannabidiol industry-sponsored liver safety study has indicated a good safety profile for...